Sari Aslani Fatemeh, Kargar Hadis, Safaei Akbar, Jowkar Farideh, Hosseini Motahareh, Sepaskhah Mozhdeh
Dermatology, Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, IRN.
Pathology, Shiraz University of Medical Sciences, Shiraz, IRN.
Cureus. 2020 Apr 9;12(4):e7606. doi: 10.7759/cureus.7606.
Background Although macular amyloidosis is a relatively rare disease, it is a common cutaneous disease in Asia and the Middle East. On hematoxylin and eosin (H&E) stained slides, early lesions could easily be missed without the use of special stains and/or immunohistochemistry. Methods We enrolled 42 patients with the clinical impression of macular amyloidosis who had undergone two 4-mm punch biopsies from 2015 to 2016 at a dermatology clinic affiliated to Shiraz University. Besides, 14 cases with a clinical diagnosis other than macular amyloidosis were selected as the negative control group. Congo red, crystal violet, and immunohistochemical (IHC) staining of CK5 and high molecular weight keratin (HMWK) were performed for each specimen. Results H&E slides showed globular depositions in 15 (35.7%) out of 42 patients. None of the patients showed apple-green birefringence with Congo red stain. Evaluation of crystal violet stained sections revealed purplish violet amyloid deposits in 15 (35.7%) patients. IHC study showed expression of CK5 in 52.4% and HMWK in 50% of the patients, which was not a significant difference (p = 0.715). The findings of both IHC markers had a significant difference with H&E stains (p = 0.039) and crystal violet (p = 0.008). Additionally, we found that two punch biopsies from two sites in the involved area did not have a significant preference over one punch biopsy. All of the cases in the control group were negative for amyloid deposition in H&E, special stains, and IHC stained slides as expected. Conclusions IHC evaluation using CK5 and HMWK might be a useful tool for diagnosing macular amyloidosis.
背景 尽管黄斑淀粉样变是一种相对罕见的疾病,但在亚洲和中东地区却是一种常见的皮肤疾病。在苏木精-伊红(H&E)染色切片上,如果不使用特殊染色和/或免疫组织化学方法,早期病变很容易被漏诊。方法 我们纳入了42例临床诊断为黄斑淀粉样变的患者,这些患者于2015年至2016年在设拉子大学附属皮肤科诊所接受了两次4毫米的钻孔活检。此外,选择14例临床诊断不是黄斑淀粉样变的病例作为阴性对照组。对每个标本进行刚果红、结晶紫染色以及细胞角蛋白5(CK5)和高分子量角蛋白(HMWK)的免疫组织化学(IHC)染色。结果 H&E切片显示,42例患者中有15例(35.7%)出现球状沉积。所有患者的刚果红染色均未显示苹果绿双折射。结晶紫染色切片评估显示,15例(35.7%)患者有紫红色淀粉样沉积。免疫组织化学研究显示,52.4%的患者表达CK5,50%的患者表达HMWK,差异无统计学意义(p = 0.715)。两种免疫组织化学标志物的结果与H&E染色(p = 0.039)和结晶紫染色(p = 0.008)均有显著差异。此外,我们发现,在受累区域的两个部位进行两次钻孔活检与一次钻孔活检相比,并无显著优势。正如预期的那样,对照组所有病例的H&E、特殊染色和免疫组织化学染色切片中淀粉样沉积均为阴性。结论 使用CK5和HMWK进行免疫组织化学评估可能是诊断黄斑淀粉样变的一种有用工具。